The hepatitis B virus X protein (HBx) sequence (154 aa) has been divided into six regions (A-F) based on its sequence homology with X proteins of other mammalian hepadnaviruses. Regions A, C, and E are more conserved and include all the four conserved cysteines (C7, C61, C69, and C137).
To localize the regions of HBx important for transactivation, a panel of 10 deletion mutants (X5-X14) and 4 single point mutants (X1-X4), each corresponding to a conserved cysteine residue, was constructed by site-directed mutagenesis. A HBxspecific monoclonal antibody was developed and used to confirm the expression of mutants by Western blot. Transactivation property of the HBx mutants was studied on Rous sarcoma virus-long terminal repeat (RSV-LTR) in transient transfection assays. We observed that deletion of the most conserved region A or substitution of the N-terminal cysteine (C7) had no effect on transactivation. Deletion ofthe nonconserved regions B or F also had no deleterious effects. Deletions of regions C and D resulted in a significant loss of function. Substitution of both C6' and C69 present in region C, caused almost 90%0o loss of activity that could be partially overcome by transfecting more expression plasmid. The fully conserved 9 amino acid segment (residues 132 to 140) within region E including C137 appeared to be crucial for its activity. Finally, a truncated mutant X15 incorporating only regions C to E (amino acids 58-140) was able to stimulate the RSV-LTR quite efficiently, suggesting a crucial role played by this domain in transactivation function.
Hepatitis B virus (HBV) is the infective agent for the widespread liver disease in humans known as hepatitis B. Chronic infection has been associated with a high risk for development of hepatocellular carcinoma (1, 2) . Similar viruses are also found in several animal species such as woodchucks, ground squirrels, and ducks, and together they constitute the family Hepadnaviridae. The small 3.2-kb DNA genome of HBV has at least four open reading frames called S, C, P, and X. During the natural course of HBV infection, the X gene expresses a polypeptide (HBx) of 154 residues that is implicated in HBVmediated hepatocellular carcinoma (3, 4) .
HBx is a pleiotropic transactivator because it can stimulate the cis-elements of not only the HBV genome (5, 6 ) but also of a wide range of other viral promoters such as simian virus 40 early (5, 7, 8) and herpes simplex virus-tk (7, 8) , and long terminal repeats (LTRs) of human immunodeficiency virus type 1 (9, 10), human immunodeficiency virus type 2 (11) , human T-lymphotropic virus type 1 (7) , mouse mammary tumor virus (5, 7) , and Rous sarcoma virus (RSV) (7, 8) . HBx can also upregulate the expression of some protooncogenes like c-myc (12) and c-fos/c-jun (13) (14) (15) .
Several cellular genes, such as al-antitrypsin (16) and a-fetoprotein (15); metallothionein (7) , epidermal growth factor receptor (17) , and RNA polymerase II and III (18) ; and many genes encoding components of the immune system, such as major histocompatability complex I (19) , major histocompatability complex 11 (20) , intracellular adhesion molecule 1 (21), ,3-interferon (8) , and interleukin 8 (22) , can also be activated by HBx. As HBx does not bind to DNA, it may mediate transactivation through protein-protein interactions (23) (24) (25) . Although there is no consensus among the regulatory regions of the HBxresponsive genes, most of them incorporate cis-elements for some common trans-factors like AP-1, AP-2, C/EBP, and NF-KB (22, 26) . Interestingly, HBx interacts with several other host-cell transcription factors such as ATF-2 and CREB (23, 25) , Oct-1 (27) , RBP5 subunit of RNA polymerase (28) , and the TATA binding protein (24) . Besides, it can also bind to the tumor suppressor factor p53 (29) , serine protease TL2 (30) , cellular DNA repair protein (31) , and the simian virus large tumor antigen (32) . HBx shows ATPase (33) and protein kinase activities (34) and is able to modulate cellular signal-transduction pathways (35) (36) (37) confluence in a 60-mm culture dish were cotransfected with the wild-type or mutant HBx expression vectors, and the RSV-CAT reporter plasmid was cotransfected by either the calcium phosphate method (42) or by using lipofectin reagent (GIBCO/BRL). Cell extracts were prepared 48 h posttransfection, and CAT activity was measured as described by Gorman et al. (43) by using equal amounts of protein. After thin layer chromatography and autoradiography, radioactivity of the substrate and product spots was measured by liquid scintillation counting. RESULTS Sequence Homology of HBx. Fig. 1 shows the homology in amino acid sequence of X proteins of the human hepatitis B virus (HBx), the ground squirrel hepatitis virus (GSHVx), and the woodchuck hepatitis virus (WHVx). The overall homology among the three viral proteins is about 35% with nine conserved basic amino acids and four conserved cysteines (C7, C61, C69, and C137). Further, HBx can be subdivided into at least six regions (A-F) of which the more conserved regions, A, C, and E, are interspersed with relatively variable regions B, D, and F.
Region A, containing the N-terminal 20 aa, is the most conserved segment of HBx (80% identity) including three arginines and one cysteine (C7). Rich in serine and glycine residues, region B (21-57) is poorly conserved (only 5.4% identity). With about 55% homology and rich in hydrophobic amino acids, region C spans residues 58-84 and is characterized by two conserved cysteines, C61 and C69. Located between amino acids 85 and 119, region D shows poor homology (17%), with two conserved basic amino acids. Region E, between residues 120 and 140, is well conserved (-67%) and is characterized by a stretch of nine fully conserved amino acids including a cysteine (CI37) and three basic amino acids. With (38) , GSHVx (44) , and WHVx (45). (A) Schematic alignment of the three X proteins were made by using MACAW software (46) . Identical residues are represented as dark bands. Segments of higher homology-i.e., A, C, and E-are prominently shown while gaps in C and D regions are introduced to have maximal alignment. (B) Alignment of amino acid sequences of the three X proteins using the CLUSTAL program of PC/GENE. Only the nonidentical amino acids are shown in the GSHVx and WHVx sequences. Gaps (-) are introduced in order have maximum alignment of the identical amino acid residues (*). The HBx sequence (154 amino acids) was divided into six regions (A-F) based on its homology with GSHVx and WHVx and the percent homology of each region is shown in parenthesis on the right. The three most conserved regions (A, amino acids 1-20; C, 58-84 and E, 120-140) are boxed, and the four conserved cysteines (0) and the nine conserved basic amino acids (co) are indicated.
no apparent homology, region F is highly variable in length and is longest (14 aa) in HBV.
HBx Expression Vector, HBx Mutagenesis, and Expression of the Mutants. The HBx gene (adw subtype) was PCR amplified and cloned into the pSG5 expression vector to get the XO construct. All 15 mutants were constructed by using the XO template. The four point mutants (X1-X4) and the 10 inframe deletion mutants (X5-X14) were constructed by site-directed mutagenesis (Fig. 2) . The four conserved cysProc. Natl. Acad. Sci. USA 93 (1996) Proc. Natl. Acad. teines (C7, C61, C69, and C137) were individually replaced by threonine residue in mutants X1-X4, respectively. Similarly, the six regions of HBx (i.e., A-F) were deleted in mutants X5, X6, X7, X9, X10, and X14, respectively. For a finer mapping of the transactivation domain of HBx, additional mutants were constructed for regions C (X8) and E (X11-X13). In mutant X8, the segment 71-84 of region C was deleted without affecting the two conserved cysteines C61 and C69. In mutant Xll, all the acidic amino acids of region E were deleted, whereas in X12 the three conserved basic amino acids along with C137 were deleted. The fully conserved stretch of nine amino acids in region E encompassing C137 was deleted in mutant X13. Finally, to explore if the regions of HBx identified by the above mutational study alone were sufficient for transactivation, a truncated mutant with only regions C, D, and E (X15) was constructed by PCR amplification.
Expression of the HBx mutants X1-X14 in transiently transfected COS 1 cells was verified by Western blot analysis by using the HBx-specific monoclonal antibody B-8/2/8 (Fig.  3A) . All the mutants except X9 (lane 13) expressed a specific band of the expected size. The wild-type HBx (XO) construct expressed a protein of 16.5 kDa (lane 4) with a mobility similar to the X protein expressed in E. coli (lane 2). As expected, all the point mutants (X1-X4) showed a size similar to XO (lanes 5-8) while all the deletion mutants (X5-X14) had smaller gene products (lanes 9-12 and 14-18). Mutant protein X6 with the largest deletion of 37 aa, showed the highest mobility (lane 10). No band was observed for X9 in lane 13 probably due to deletion of the epitope for the monoclonal antibody. However, expression of X9 was confirmed using an anti-X polyclonal rabbit serum (data not shown). Expression of mutant X15 could be verified only after metabolically labeling the transfected cells with [35S]methionine followed by immunoprecipitation (Fig. 3B, lane 4) 3 and 4) suggests the labile nature of X15 when expressed in mammalian cells. No such problem was observed when this mutant was expressed in E. coli (data not shown).
Localization of Region(s) Essential for Transactivation. Functional analysis of the HBx mutants was done by transiently transfecting them in Hep G2 cells together with the reporter construct, RSV-CAT that contains the LTR of RSV (43) . The sensitivity of the assay was determined by transfecting increasing amounts of the reporter in the absence or presence of a fixed amount (1 ,ug) of XO plasmid. X-mediated stimulation of CAT activity could be detected even when 0.1 ,ug of the reporter construct was used (Fig. 4A) . Maximum stimulation (-3-to 6-fold) of RSV-LTR by XO was seen with 0.5 ,ug of RSV-CAT, which plateaued at higher concentrations of the reporter. Therefore, in all subsequent experiments, only 0.5 ,ug of RSV-CAT plasmid was used. Further, we also determined the activation curve for XO and worked out the conditions under which functional analysis of the HBx mutants could be done without having a squelching effect. It was observed that with 0.5 ,g of the transfecting RSV-CAT plasmid, the enzyme activity peaked (-11-fold stimulation) in the presence of 5 ,ug of the cotransfecting XO plasmid, but declined when 10 jig of the plasmid was used (Fig. 4B) . Therefore, functional analysis of all the HBx mutants was carried out at three submaximal plasmid concentrations of 0.5, 1, and 2.5 ,ug.
The results of mutational analyses are presented in Table 1 . We observed that deletion of the most conserved N-terminal region A (X5) had no effect on the HBx-mediated transactivation. Interestingly, deletion of the nonconserved regions B and F in mutants X6 and X14, respectively, also did not alter A 6 *xo the levels of transactivation. However, a significant decrease in transactivation of about 50-80% was seen when the entire region C (X7) or its portion (X8) were deleted. Similarly, deletion of the poorly conserved region D (X9) also showed nearly a 50% drop in the transactivation level. The fully conserved nine amino acid segment (residues 132-140) of region E appeared crucial for the activity because all deletions involving this segment (X10, X12, and X13) resulted in a 5-to 10-fold decrease in activity. Surprisingly, deletion of the segment 120-128, which is rich in acidic residues (Xll), resulted in only a marginal decline (up to 35%) in transactivation. These results suggest that the HBx segment spanning regions C to E (i.e., residues 58-140) is important for its transactivation function. Interestingly, in cotransfection experiments none of the inactive or poorly active mutants was able to suppress the XO activity (data not shown).
The C-Terminal Cysteine (C'37) Is Important for Transactivation Function. Involvement of the four conserved cysteines in the HBx-mediated transactivation was studied by using the point mutants X1-X4. We observed that substitution of the N-terminal conserved cysteine C7 (X1) had no effect on the ability of the mutant to transactivate RSV-LTR (Table 1) . Point mutations of the other three conserved cysteines-i.e., C61, C69 and C137 (in X2-X4, respectively)-however, resulted in a dramatic loss (-10-fold) in the transactivation property of HBx when 0.5 jig of the expression vectors were transfected.
For X2 and X3, this effect was, however, partially overcome by transfecting more (2.5 jig) mutant plasmid. Mutant X4 remained inactive under similar conditions (see Table 1 ). Thus, the integrity of the conserved C-terminal cysteine C'37 of HBx was essential for its transactivation function.
A Mutant with Only C, D, and E Regions Is an Efficient Transactivator. After identifying the regions of HBx that were involved in transactivation, we planned to explore the possibility of having a functional mutant with just the minimal activation domain of HBx. Thus, using PCR, we constructed a truncated mutant X15 with only regions C, D, and E (residues 58-140) and determined a transactivation curve for X15 by using the experimental protocols described for XO. Analysis of the curves (Fig. 4B) as well as subsequent comparative mutational analyses (Table 1) showed that X15 was able to stimulate the RSV-LTR quite efficiently. Although the level of stimulation was about 60% of the wild type when 0.5 ,ug of the X15 plasmid was used, the stimulation values were at par with each other when plasmid dosages were 1 and 2.5 ,ug, respectively. Cotransfection of XO and X15 showed an additive effect on transactivation (data not shown). Apparently, the target interaction and the transactivation functions of HBx converge in the same domain represented by X15.
DISCUSSION
We have investigated the regions of HBx that are important for its transactivation function. Our mutational analysis has identified a segment in the C terminus of HBx corresponding to regions C, D, and E that is essential for its activity. We found that deletions involving either the entire E region (X10) or its fully conserved segment of nine amino acids (X13) as well as substitution of the conserved cysteine (C'37) of this region (X4) resulted in a drastic loss of function. The difference in the transactivation property is unlikely to be related to the expression levels because all the mutants appeared to be expressed with equal efficiency. Thus, HBx region E is crucial for its transactivation property. Likewise, deletion of the entire C region (X7) or its portions (X8) as well as substitution of the conserved cysteines C61 and C69 of this region (X2 and X3) were equally deleterious. There was, however, one important difference about the C-region mutants in that their effect could be partially overcome by transfecting more expression plasmids. Therefore it is unlikely that region C with two (33) , its relevance in transcriptional regulation is not known. Nevertheless, the epitope for the monoclonal antibody used in this study appears to be localized in region D because it failed to recognize mutant X9. It was puzzling, however, to observe that deletion of the most conserved region A (X5) or mutation of the N-terminal conserved cysteine (X1) had no bearing on the transactivation function of HBx. Recent reports suggest that region A may have a role in transrepression (48) (49) (50) . The poorly conserved region B (X6) and nonconserved region F (X14) are unlikely to have a major role in transactivation.
Mutational analyses of HBx using different rationales and approaches have been attempted by several groups. Using linker insertion mutagenesis, Runkel et al. (51) were able to localize two separate regions of HBx that were important for transactivation (one around amino acid 68 and the other between segments 110 and 139). Other reports on the mutational studies of HBx (13, 48, 49, 52) suggest that its transactivation region is localized toward the C-terminal region. However most of these analyses are based primarily on the loss of reporter function. In the present study, we have mapped the "minimum functional domain" of HBx that could show transactivation function. On the basis of our results of deletion and point mutagenesis, a highly truncated mutant X15 (with only regions C, D, and E) was constructed. Although the gene product was relatively unstable in mammalian cell lines, it was able to show a transactivation property like the wild-type HBx. Thus, segments 58-140 or regions C-E of HBx is the minimum domain involved in transactivation function. Interestingly, two important sequence regions of HBx (i.e., C and E, identified by us) also map to the regions that interact the RPB5 subunit of RNA polymerase (28) as well as a serine protease (30) . These interactions have been proposed to influence the transactivation function of HBx. The role of region E in transactivation is further substantiated by the fact that the TATAbinding protein, which is considered central to transcription regulation, also interacts with HBx through this region (24) .
Further, we find an interesting correlation of our work with the naturally occurring variants of HBV (usually sero-negative by ELISA). DNA sequence analysis of some of these variants has shown that very often their genomes have deletions or premature "stop" codons around region E of the X gene (6, (53) (54) (55) . The presence of a mutated X protein in those cases might be responsible for a subdued expression of the HBV genes. Yet another interesting possibility could be the integration of a minimum transactivation region (similar to X15) of the HBx gene in HBV carriers. Analysis of patient sera using a sensitive ELISA based on this region and/or PCR amplification of this region of the X gene should provide interesting results and more insight into HBV-related pathogenesis.
